| • High concentration in the heart muscle |
| • Absence from other non-cardiac tissue |
| • Rapid release into the blood following myocardial injury |
| • High sensitivity and specificity in laboratory serum samples |
| • Favorable kinetics for detection of myocardial damage and acute coronary syndrome in the hours or days when patients seek medical attention |
| • Correlation between cardiac biomarker and extent of myocardial injury and prognosis |
| • Wide-spread assay availability that are simple, automated, and rapid |
| • Well-defined role in diagnosis and management based on medical peer-reviewed literature and clinical trials |
